Despite a growing body of clinical data suggesting an increased risk of GC among BRCA1 and BRCA2 carriers, there is limited research investigating the underlying pathogenesis, and at this time no concrete mechanism of gastric carcinogenesis [1]. The gene discussed is BRCA2; the disease is gastric cancer.